Stay updated on LN-145 & Durvalumab Combo in NSCLC Clinical Trial
Sign up to get notified when there's something new on the LN-145 & Durvalumab Combo in NSCLC Clinical Trial page.

Latest updates to the LN-145 & Durvalumab Combo in NSCLC Clinical Trial page
- Check3 days agoChange DetectedThe page now displays Revision: v3.6.3, replacing the previous v3.6.2. This indicates a small update to the page tooling or template, while the visible study information and structure remain the same.SummaryDifference0.1%

- Check10 days agoChange DetectedFooter revision label updated from v3.6.0 to v3.6.2, signaling a newer page release. This change does not modify any study content, eligibility criteria, or results.SummaryDifference0.1%

- Check17 days agoChange DetectedThere are no additions or deletions reported for this study page. The page content remains unchanged as a result.SummaryDifference0.1%

- Check24 days agoChange DetectedAdded user-help sections: How to Read a Study Record, Common Questions, How to Join a Study, and a formatting update for Intervention/Treatment. Release notes were updated to Revision: v3.6.0.SummaryDifference0.5%

- Check31 days agoChange DetectedThe page revision stamp changed from v3.5.4 to v3.5.5, indicating a new version of the page. This appears to reflect an update to the page's version rather than a substantive content change.SummaryDifference0.1%

- Check53 days agoChange DetectedThe revision label was updated from v3.5.3 to v3.5.4, representing a newer documented version of the page.SummaryDifference0.1%

Stay in the know with updates to LN-145 & Durvalumab Combo in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LN-145 & Durvalumab Combo in NSCLC Clinical Trial page.